International benchmarking of stage at diagnosis for six childhood solid tumours (the BENCHISTA project): a population-based, retrospective cohort study.

Date publication

février 2025

Journal

The Lancet. Child & adolescent health

Auteurs

Membres identifiés du Cancéropôle Est :
Dr DESANDES Emmanuel

Tous les auteurs :
Botta L, Didonè F, Lopez-Cortes A, Nieto AC, Desandes E, Hjalgrim LL, Jakab Z, Stiller CA, Zeller B, Gatta G, Pritchard-Jones K,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39855760

Résumé

International variation in childhood cancer survival might be explained by differences in stage at diagnosis, among other factors. As part of the BENCHISTA project, we aimed to assess geographical variation in tumour stage at diagnosis through the application, by population-based cancer registries working with clinicians, of the international consensus Toronto Childhood Cancer Stage Guidelines.

Mots clés

Humans, Retrospective Studies, Child, Adolescent, Male, Female, Child, Preschool, Infant, Neuroblastoma, pathology, Neoplasm Staging, Wilms Tumor, pathology, Benchmarking, Sarcoma, Ewing, pathology, Infant, Newborn, Rhabdomyosarcoma, diagnosis, Registries, Medulloblastoma, diagnosis, Osteosarcoma, diagnosis, Europe, epidemiology, Canada, epidemiology, Australia, epidemiology, Brazil, epidemiology, Neoplasms, pathology, Cohort Studies, Japan, epidemiology

Référence

Lancet Child Adolesc Health. 2025 02;9(2):89-99